Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05356897
Title Tucatinib Combined With Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Trastuzumab + Trifluridine-tipiracil hydrochloride + Tucatinib

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST